A detailed history of Jaffetilchin Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jaffetilchin Investment Partners, LLC holds 13,924 shares of LLY stock, worth $12.6 Million. This represents 1.09% of its overall portfolio holdings.

Number of Shares
13,924
Previous 13,751 1.26%
Holding current value
$12.6 Million
Previous $10.7 Million 17.85%
% of portfolio
1.09%
Previous 0.97%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$724.87 - $909.04 $125,402 - $157,263
173 Added 1.26%
13,924 $12.6 Million
Q1 2024

May 16, 2024

BUY
$592.2 - $792.28 $224,443 - $300,274
379 Added 2.83%
13,751 $10.7 Million
Q4 2023

Feb 13, 2024

SELL
$525.19 - $619.13 $262,069 - $308,945
-499 Reduced 3.6%
13,372 $7.79 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $91,287 - $125,852
210 Added 1.54%
13,871 $7.45 Million
Q2 2023

Aug 15, 2023

SELL
$350.74 - $468.98 $239,906 - $320,782
-684 Reduced 4.77%
13,661 $6.41 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $353,496 - $415,165
1,138 Added 8.62%
14,345 $4.93 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $70,097 - $81,678
-218 Reduced 1.62%
13,207 $4.83 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $147,647 - $168,259
498 Added 3.85%
13,425 $4.34 Million
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $150,514 - $176,725
540 Added 4.36%
12,927 $4.19 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $438,400 - $544,820
1,868 Added 17.76%
12,387 $3.61 Million
Q4 2021

Feb 17, 2022

SELL
$224.85 - $279.04 $174,933 - $217,093
-778 Reduced 6.89%
10,519 $2.91 Million
Q3 2021

Oct 25, 2021

SELL
$221.6 - $272.71 $1.53 Million - $1.88 Million
-6,911 Reduced 37.96%
11,297 $2.61 Million
Q2 2021

Aug 09, 2021

BUY
$180.55 - $233.54 $1.66 Million - $2.15 Million
9,206 Added 102.27%
18,208 $3.75 Million
Q1 2021

May 10, 2021

BUY
$164.32 - $212.72 $310,564 - $402,040
1,890 Added 26.57%
9,002 $1.68 Million
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $401,164 - $530,837
3,075 Added 76.17%
7,112 $1.2 Million
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $271,384 - $313,905
1,856 Added 85.1%
4,037 $598,000
Q2 2020

Aug 03, 2020

BUY
$136.42 - $164.18 $295,622 - $355,778
2,167 Added 15478.57%
2,181 $358,000
Q2 2020

Jul 31, 2020

SELL
$136.42 - $164.18 $345,551 - $415,867
-2,533 Reduced 99.45%
14 $358,000
Q1 2020

May 06, 2020

BUY
$119.05 - $147.35 $72,263 - $89,441
607 Added 31.29%
2,547 $353,000
Q4 2019

Jan 28, 2020

SELL
$106.92 - $132.43 $6,842 - $8,475
-64 Reduced 3.19%
1,940 $255,000
Q3 2019

Oct 15, 2019

SELL
$106.79 - $116.16 $17,193 - $18,701
-161 Reduced 7.44%
2,004 $224,000
Q2 2019

Aug 13, 2019

SELL
$110.79 - $129.32 $110,346 - $128,802
-996 Reduced 31.51%
2,165 $240,000
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $110,530 - $130,102
-993 Reduced 23.9%
3,161 $410,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $177,806 - $199,196
1,679 Added 67.84%
4,154 $481,000
Q3 2018

Oct 05, 2018

BUY
$85.86 - $107.31 $212,503 - $265,592
2,475 New
2,475 $266,000
Q4 2017

Jan 10, 2018

SELL
$81.94 - $87.89 $870,858 - $934,094
-10,628 Closed
0 $0
Q3 2017

Nov 03, 2017

BUY
$77.07 - $85.54 $819,099 - $909,119
10,628
10,628 $909,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $859B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Jaffetilchin Investment Partners, LLC Portfolio

Follow Jaffetilchin Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jaffetilchin Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jaffetilchin Investment Partners, LLC with notifications on news.